Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Steger

Showing results (191-200 of 320) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemiaW Reinisch, M Willheim, M Hilgarth, et al.
BMC Clinical Pharmacology|July 21, 2007
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxelRupert Bartsch, Guenther G Steger, Birgit Forstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trialRupert Bartsch, Catharina Wenzel, Ursula Pluschnig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year resultsM F Gnant, G H Blijham, A Reiner, et al.
Breast (Edinburgh, Scotland)|May 20, 2008
Factors influencing the time to development of brain metastases in breast cancerSabine Fromm, Rupert Bartsch, Margaretha Rudas, et al.
The Breast Journal|April 1, 2011
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14Christoph Tausch, Gunther G Steger, Anton Haid, et al.
Biochemical Pharmacology|January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroR M Mader, A E Sieder, J Braun, et al.
Cancer Genetics and Cytogenetics|July 1, 1992
Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLC Marosi, U Köller, E Koller-Weber, et al.
Pageof 32

Showing results (191-200 of 320) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemiaW Reinisch, M Willheim, M Hilgarth, et al.
BMC Clinical Pharmacology|July 21, 2007
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxelRupert Bartsch, Guenther G Steger, Birgit Forstner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trialRupert Bartsch, Catharina Wenzel, Ursula Pluschnig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year resultsM F Gnant, G H Blijham, A Reiner, et al.
Breast (Edinburgh, Scotland)|May 20, 2008
Factors influencing the time to development of brain metastases in breast cancerSabine Fromm, Rupert Bartsch, Margaretha Rudas, et al.
The Breast Journal|April 1, 2011
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14Christoph Tausch, Gunther G Steger, Anton Haid, et al.
Biochemical Pharmacology|January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroR M Mader, A E Sieder, J Braun, et al.
Cancer Genetics and Cytogenetics|July 1, 1992
Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLC Marosi, U Köller, E Koller-Weber, et al.
Pageof 32